Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients
DiabetologiaPublished 1 August 2002Open access
T. Vilsb x F ll, Thure Krarup, Sten Madsbad, Jens J. Holst
Citations514
SJR quartileQ1
SJR score3.62
SNIP2.67
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Lack of GIP amplification of the late phase insulin response to glucose, which contrasts markedly to the normalising effect of GLP-1, could be a key defect in insulin secretion in Type II diabetic patients.
Abstract
Lack of GIP amplification of the late phase insulin response to glucose, which contrasts markedly to the normalising effect of GLP-1, could be a key defect in insulin secretion in Type II diabetic patients.
Keywords
Medicine
Diabetic MedicineDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
15,141 Citations1998K. G. M. M. Alberti, Paul Zimmet +1 more
A WHO Consultation has taken place in parallel with a report by an American Diabetes Association Expert Committee to re‐examine diagnostic criteria and classification of diabetes mellitus and is hoped that the new classification will allow better classification of individuals and lead to fewer therapeutic misjudgements.
Journal of Clinical InvestigationPreserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
1,641 Citations1993Michael A. Nauck, Markus M. Heimesaat +4 more
In mild type-2 diabetes, GLP-1 [7-36 amide], in contrast to GIP, retains much of its insulinotropic activity and lowers glucagon concentrations.
DiabetologiaReduced incretin effect in Type 2 (non-insulin-dependent) diabetes
1,305 Citations1986Michael A. Nauck, F. Stöckmann +2 more
Integrated incremental immunoreactive insulin and connecting peptide responses to an oral glucose load and an “isoglycaemic” intravenous glucose infusion, respectively, were measured in 14 Type 2 diabetic patients and 8 age- and weight-matched metabolically healthy control subjects.
Endocrine ReviewsThe Glucagon-Like Peptides
1,016 Citations1999Timothy J. Kieffer, Joel F. Habener
The aim of this monograph is to clarify the role of Incretin in the development of Glucagon-Related Peptides in women and to provide a mechanistic basis for future research into their role in women's health.
DiabetesTissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
892 Citations1994Cathrine Ørskov, L. Rabenhøj +3 more
Both amidated and glycine-extended GLP-I molecules are produced in the small intestine and in the pancreas in humans and both are measurable in fasting plasma.
DiabetesReduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
884 Citations2001Tina Vilsbøll, Thure Krarup +3 more
The measurement of intact incretin hormones revealed that total as well as intact GIP responses were minimally decreased in patients with type 2 diabetes, whereas the late intact GLP-1 response was strongly reduced, supporting the hypothesis that an impaired function of GLp-1 as a transmitter in the enteroinsular axis contributes to the inappropriate insulin secretion in type 2 diabetic patients.
The Journal of Clinical Endocrinology & MetabolismIncretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*
875 Citations1986Michael A. Nauck, ERWIN HOMBERGER +5 more
A discrepancy between the estimates of the incretin effect derived from peripheral venous insulin responses, and C-peptide responses or calculated insulin secretion rates, exists, which suggests that elimination kinetics of insulin differ between oral and iv glucose administration.
DiabetologiaRadioimmunological determination of human C-peptide in serum
835 Citations1975Lise G. Hedïng
It is suggested that displacement found with most antisera is due to substances in serum that are not related to C-peptide or proinsulin, and Serial dilutions of pancreatic extracts and sera may yield dilution curves slightly different to those of the synthetic standard.
The Journal of Clinical Endocrinology & MetabolismDegradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide<sup>1</sup>
400 Citations2000Carolyn F. Deacon, Michael A. Nauck +3 more
It is concluded that dipeptidyl peptidase IV is important in GIP metabolism in humans in vivo, and that an N-terminally directed assay is required for determination of plasma concentrations of biologically active GIP.
Journal of Clinical InvestigationProglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.
380 Citations1991Cathrine Ørskov, Jørgen Jeppesen +2 more
The elevated levels of immunoreactive GLP-1 in diabetics in the fasting state were mainly due to an increased concentration of major proglucagon fragment, an insulinotropic hormone.
Regulatory PeptidesThe insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects
310 Citations1994Dariush Elahi, M. McAloon-Dyke +6 more
It is concluded that in normal healthy subjects, GLP-1(7-37), on a molar basis, is several times more potent than GIP at equivalent glycemic conditions, and may have therapeutic potential as a hypoglycemic agent in NIDDM patients.
Pflügers Archiv - European Journal of PhysiologyCellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1
260 Citations1998Jesper Gromada, Jens J. Holst +1 more
The actions of GLP-1 on islet cell function are reviewed and current knowledge is integrated into a working model for the control of pancreatic hormone secretion to establish a novel principle for the treatment of human type-2 diabetes.
DiabetesCharacterization of Seven C-peptide Antisera
230 Citations1978O. K. Faber, Christian Binder +7 more
Differences in C-peptide antisera are a major reason for the variation in the concentration of circulating CPR as measured in different, C- peptide immunoassays.
DiabetesReduced Insulinotropic Effect of Gastric Inhibitory Polypeptide in First-Degree Relatives of Patients With Type 2 Diabetes
229 Citations2001Juris J. Meier, Katrin Hücking +4 more
A reduced insulinotropic activity of GIP is typical for a substantial subgroup of normoglycemic first-degree relatives of patients with type 2 diabetes, pointing to an early, possibly genetic defect.
The Journal of Clinical Endocrinology & MetabolismDiminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*
152 Citations1983Thure Krarup, Sten Madsbad +5 more
The release of immunoreactive gastric inhibitory polypeptide (IR-GIP) in response to a standard meal was examined in 10 normal subjects and 15 type I (insulin-dependent) diabetics 7 days, 14 days, and 3 months after time of diagnosis to identify responses that may significantly influence insulin levels and hyperglycemia.
DiabetesGlucagon-Like Peptide I Increases Cytoplasmic Calcium in Insulin-Secreting βTC3-Cells by Enhancement of Intracellular Calcium Mobilization
125 Citations1995Jesper Gromada, Steen Dissing +5 more
DiabetesProtein Kinase A-Dependent Stimulation of Exocytosis in Mouse Pancreatic β-Cells by Glucose-Dependent Insulinotropic Polypeptide
118 Citations1997Wei‐Guang Ding, Jesper Gromada
The data indicate that the insulinotropic hormone GIP stimulates insulin secretion from pancreatic β-cells, through the cAMP/PKA signaling pathway, by interacting with the secretory machinery at a level distal to an elevation in [Ca2+]i.
DiabetologiaThe pathogenesis of NIDDM involves a defective expression of the GIP receptor
112 Citations1997Jens J. Holst, Jesper Gromada +1 more
In patients with mod-erate disease, insulin secretion (as estimated by C-peptide responses) was near normal when compared to that of healthy control subjects under the condi-tions of an identical hyperglycaemic clamp, and GLP-1 is strongly insulino-tropic in these patients.
Regulatory PeptidesThe heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera
110 Citations1984Thure Krarup, Jens J. Holst
The present results indicate that human and porcine 5 kDa GIP differ in chemical composition.
Diabetes CarePotential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet
99 Citations1996M. Gutniak, Hillevi Larsson +4 more
Therapeutic plasma levels of GLP-I in humans were achieved after a single buccal tablet, and no increased degradation ofglucagon-like peptide I was found in the buCCal mucosa compared to subcutaneous tissue.
Diabetes CareGlucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas
70 Citations1996M. Gutniak, Lisa Juntti‐Berggren +4 more
In acute experiments on overweight patients with NIDDM, GLP-I exerted a marked antidiabetogenic action on the basal and postprandial state and in patients with secondary failure to sulfonylureas.
FEBS LettersStimulation of cloned human glucagon‐like peptide 1 receptor expressed in HEK 293 cells induces cAMP‐dependent activation of calcium‐induced calcium release
68 Citations1995Jesper Gromada, Patrik Rorsman +2 more
The ability of GLP‐1(7–36)amide to increase [Ca2+]i results from sensitization of the ryanodine receptors by a protein kinase A dependent mechanism.
DiabetologiaDiscovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells
67 Citations1998Katrine Almind, Louise Ambye +7 more
In conclusion, amino acid variants in the GIP receptor are not associated with random Type II diabetes in patients of Danish Caucasian origin or with altered GIP binding and GIP-induced cAMP production when stably transfected in Chinese hamster fibroblasts.
DiabetesIdentification of Two Missense Mutations in the GIP Receptor Gene: A Functional Study and Association Analysis with NIDDM: No Evidence of Association with Japanese NIDDM Subjects
60 Citations1996Akira Kubota, Yuichiro Yamada +9 more
Investigation of the entire coding region of the GIP receptor gene by polymerase chain reaction-single strand conformational polymorphism reveals two missense mutations, Gly198→Cys and Glu354→Gln, which reveal a half-maximal stimulation value of GIP-induced cAMP response in Chinese hamster ovary cells expressing the G IP receptor with Gly198Cys.
American Journal of Physiology-Gastrointestinal and Liver PhysiologySignal transmission after GLP-1(7-36)amide binding in RINm5F cells
56 Citations1989Rüdiger Göke, ME Trautmann +5 more
The effect of guanine nucleotides on binding of GLP-1(7-36)amide indicates that the action of the peptide is mediated by the adenylate cyclase system, and is unlikely to be involved in the inositol 1,4,5-trisphosphate pathway.
Radioimmunological Determination of Human C-Peptide in Serum
48 Citations1988L. G. Heding
Regulatory Peptideschimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1
41 Citations1996Baptist Gallwitz, M Witt +3 more
All hybrid peptides investigated showed minimal binding affinity for the GIP receptor, indicating that the entire GIP-sequence (1-31) is important for receptor recognition.
Diabetes CareThe Effect of Glyburide on β-Cell Sensitivity to Glucose-Dependent Insulinotropic Polypeptide
40 Citations1993Graydon S. Meneilly, Michael Bryer‐Ash +1 more
It is concluded that glyburide enhances β-cell sensitivity to GIP in NIDDM patients in a meal study and a 2-h hyperglycemic glucose clamp study.
Diabetes CareEvaluation of beta-cell secretory capacity using glucagon-like peptide 1.
37 Citations2000Tina Vilsbøll, M. Toft-Nielsen +4 more
GLP-1 elicits similar secretory responses to 1 mg glucagon (but has fewer side effects) and a standard meal and a hyperglycemia had an additional effect on the response to arginine.
DiabetesGlucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization
20 Citations1995Jesper Gromada, Steen Dissing +5 more
In the insulin-secreting beta-cell line beta TC3, stimulation with 11.2 mmol/l glucose caused a rise in the intracellular free Ca2+ concentration ([Ca2+]i), and it is proposed that this novel action of GLP-I(7-36)amide represents an important factor contributing to its insulinotropic action.
DiabetesAltered Glucose Dependence of Glucagon-Like Peptide I(7–36)–Induced Insulin Secretion from the Zucker (<i>fa/fa</i>) Rat Pancreas
17 Citations1995Xiaoyan Jia, Ruan Elliott +3 more
In adult obese Zucker rats, GLP-I may contribute to the fasting hyperinsulinemia seen in vivo, and there appears to be a general reduction in the glucose dependence of responses to incretins.